Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment
- 30 June 2004
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 46 (8) , 1141-1157
- https://doi.org/10.1016/j.neuropharm.2004.02.009
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor AutoradiographyThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retinaJournal of Neurochemistry, 2003
- Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine ReceptorsMolecular Pharmacology, 2003
- Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiographyJournal of Neurochemistry, 2002
- The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptorNeuropharmacology, 2000
- Nicotinic-agonist stimulated 86Rb+ efflux and [3H]epibatidine binding of mice differing in β2 genotypeNeuropharmacology, 2000
- Identification of a novel nicotinic binding site in mouse brain using [125I]‐epibatidineBritish Journal of Pharmacology, 2000
- Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brainNature, 1995
- Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specificBrain Research, 1993
- Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human BrainJournal of Neurochemistry, 1988